Valuation Novartis AG

Equities

Real-time Estimate Cboe Europe Other stock markets 11:20:00 2024-12-02 am EST			5-day change	1st Jan Change
93.16 ^CHF	-0.12%		+1.26%	+9.69%

04:42pm	PTC Therapeutics Strikes Up to $2.9 Billion Licensing Deal With Novartis for Huntington's Disease Drug Candidate	MT
03:25pm	Sector Update: Health Care Stocks Mixed Pre-Bell Monday	MT

Data adjusted to current consolidation scope

Fiscal Period: Dicembre	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	214,953	215,322	196,458	194,448	207,167	211,467	-	-
Change	-	0.17%	-8.76%	-1.02%	6.54%	2.08%	-	-
Enterprise Value (EV) ¹	230,853	239,822	204,649	203,482	219,178	225,096	224,300	220,055
Change	-	3.88%	-14.67%	-0.57%	7.71%	2.7%	-0.35%	-1.89%
P/E ratio	30.4x	26.7x	8.2x	28.3x	14.1x	19.3x	16.4x	15.2x
PBR	3.88x	3.78x	2.9x	3.23x	4.41x	4.72x	4.59x	4.22x
PEG	-	1.9x	0x	-0.4x	0x	-0.8x	0.9x	2.04x
Capitalization / Revenue	4.53x	4.43x	3.81x	3.85x	4.56x	4.2x	4.02x	3.97x
EV / Revenue	4.87x	4.93x	3.96x	4.03x	4.82x	4.47x	4.26x	4.13x
EV / EBITDA	14.6x	14.2x	11.2x	10.9x	12.2x	11.3x	10.4x	9.9x
EV / EBIT	16.4x	15.6x	12.3x	12.2x	13.4x	11.9x	11.2x	10.7x
EV / FCF	17.9x	20.5x	15.4x	17x	16.6x	15.3x	13.9x	12.9x
FCF Yield	5.58%	4.87%	6.49%	5.87%	6.01%	6.55%	7.2%	7.74%
Dividend per Share ²	3.025	3.375	3.36	3.5	3.823	3.767	3.923	4.143
Rate of return	3.19%	3.57%	3.83%	3.87%	3.79%	3.56%	3.71%	3.92%
EPS ²	3.12	3.55	10.71	3.19	7.15	5.492	6.46	6.941
Distribution rate	97%	95.1%	31.4%	110%	53.5%	68.6%	60.7%	59.7%
Net sales ¹	47,445	48,659	51,626	50,545	45,440	50,371	52,646	53,263
EBITDA ¹	15,809	16,845	18,246	18,613	17,937	19,964	21,504	22,226
EBIT ¹	14,112	15,416	16,588	16,665	16,372	18,963	20,045	20,524
Net income ¹	7,147	8,072	24,021	6,955	14,854	11,017	12,574	13,274
Net Debt ¹	15,900	24,500	8,191	9,034	12,011	13,629	12,833	8,588
Reference price ²	94.92	94.67	87.82	90.40	100.79	105.77	105.77	105.77
Nbr of stocks (in thousands)	2,264,608	2,274,506	2,237,092	2,150,980	2,055,460	1,999,270	-	-
Announcement Date	1/29/20	1/26/21	2/2/22	2/1/23	1/31/24	-	-	-

¹USD in Million²USD

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
NOVARTIS AG	19.26x	4.47x	11.27x	+3.56%	211B
ELI LILLY AND COMPANY	62.29x	16.15x	45.73x	+0.65%	716B
NOVO NORDISK A/S	33.54x	11.65x	23.53x	+1.49%	474B
JOHNSON & JOHNSON	22.6x	4.34x	12.64x	+3.15%	373B
ABBVIE INC.	38.5x	6.8x	14.73x	+3.41%	323B
MERCK & CO., INC.	14.3x	4.37x	10.29x	+3.00%	257B
ROCHE HOLDING AG	15.42x	3.64x	9.49x	+3.85%	233B
ASTRAZENECA PLC	24.83x	4.35x	13.59x	+2.30%	209B
AMGEN INC.	31.3x	6.04x	10.52x	+3.21%	152B
PFIZER, INC.	16.54x	3.29x	8.53x	+6.42%	149B
Average	27.86x	6.51x	16.03x	+3.10%	309.77B
Weighted average by Cap.	33.94x	8.44x	21.41x	+2.52%